好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Effect of Neuro-hospitalist Program on Health Care Outcomes: An Observational Cohort Study & Narrative Review
General Neurology
P8 - Poster Session 8 (11:45 AM-12:45 PM)
2-001

To determine the effect of a neurohospitalist-based service on quality improvement metrics for inpatient neurology admissions compared to a non-neurohospitalist service.

Neurohospitalists may improve inpatient cost and length-of-stay (LOS) when compared to non-neurohospitalists. However, there exists conflicting evidence surrounding this topic. The purpose of this study was to compare LOS, cost of care, and 30-day readmissions before and after implementation of a neurohospitalist program at our institution.

We conducted a retrospective cohort study including all inpatients treated by our neurology providers before and after the implementation of a neurohospitalist program. Patient demographics and outcomes, including LOS, cost-of-care, and 30-day readmission were compared between the pre-neurohospitalist period (10/2016-06/2019) and the neurohospitalist period (NHP) (07/2019-12/2020) using multivariable regression.

Of the 10,194 patients admitted during the study period, 1,672 were admitted to a neurology service. There was no difference in LOS between the two periods (median 6d [IQR 3-11] vs. 6d [IQR 3-12], p=0.97), however, after adjustment for contributors to LOS, there was a significant reduction in hospital stay during the neurohospitalist period (β =-0.046, 95%CI -0.085- -0.006, p=0.03). Cost was significantly higher during the NHP in unadjusted (β 0.13, 95%CI 0.09-0.17, p<0.01) and fully adjusted (β 0.13, 95%CI 0.09-0.17, p<0.01) linear regression. In that model, admission to the neurology service was associated with significantly lower costs (β -0.51, 95%CI -0.57- -0.44, p<0.01) while admission to an intensive care unit (β 0.59, 95%CI 0.53-0.64, p<0.01) and transfer from an outside institution (β 0.19, 95%CI 0.14-0.24, p<0.01) were associated with greater costs. Readmission rates were no different between periods, after adjustment (p=0.60).

Following the implementation of a neurohospitalist program, LOS was significantly decreased among neurology inpatients, while cost increased. Admission to a neurology service versus a neurology consultation was associated with reduced costs, presumably related to medical complexity associated with patients requiring subspecialty consultation.

Authors/Disclosures
Justin M. Tiongson
PRESENTER
Mr. Tiongson has nothing to disclose.
No disclosure on file
James E. Siegler III, MD (University of Chicago) Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.